🕵️ ARS Pharmaceuticals, Inc. ($SPRY)
SEC insider & ownership activity, last 12 months · CIK 1671858 · every row links its SEC filing
Over the last 12 months insiders sold $1.9M with no open-market buying against it. Justin Chakma sold $1.5M in discretionary trades (Nov). 13 planned sales are pending, the largest $421K (Richard Lowenthal). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $1.9M (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Justin Chakma | 0 | – | 2 | $1.5M | Nov 12, 2025 |
| Eric Karas | 0 | – | 1 | $250K | Jun 12, 2026 |
| Brian T. Dorsey | 0 | – | 1 | $190K | Nov 13, 2025 |
| Alexander Fitzpatrick | 0 | – | 1 | $34K | Jun 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 11.1% | 13D | Sep 29, 2025 | filing ↗ | |
| Peter Kolchinsky | 11.1% | 13D | Sep 29, 2025 | filing ↗ | |
| Rajeev Shah | 11.1% | 13D | Sep 29, 2025 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 10.1% | 13D | Sep 29, 2025 | filing ↗ | |
| Rubric Capital Management LP | 8.1% | 13G | May 15, 2026 | filing ↗ | |
| David Rosen | 8.1% | 13G | May 15, 2026 | filing ↗ | |
| James E. Flynn | 7.8% | 13D | Jul 30, 2025 | filing ↗ | |
| Deerfield Management Company, L.P. | 7.8% | 13D | Jul 30, 2025 | filing ↗ | |
| BlackRock, Inc. | 5.3% | 13G | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Richard Lowenthal | $177K | Sep 11, 2026 | filing ↗ |
| Eric Karas | $70K | Sep 11, 2026 | filing ↗ |
| Richard Lowenthal | $421K | Sep 4, 2026 | filing ↗ |
| Richard Lowenthal | $116K | Sep 3, 2026 | filing ↗ |
| Richard Lowenthal | $5K | Sep 2, 2026 | filing ↗ |
| Sarina Tanimoto | $273K | Sep 1, 2026 | filing ↗ |
| Sarina Tanimoto | $368K | Aug 31, 2026 | filing ↗ |
| Sarina Tanimoto | $148K | Aug 20, 2026 | filing ↗ |
| Richard Lowenthal | $148K | Aug 20, 2026 | filing ↗ |
| Sarina Tanimoto | $161K | Aug 19, 2026 | filing ↗ |
| Richard Lowenthal | $322K | Aug 19, 2026 | filing ↗ |
| Sarina Tanimoto | $311K | Aug 18, 2026 | filing ↗ |
| Richard Lowenthal | $316K | Aug 18, 2026 | filing ↗ |
| Eric Karas | $250K | Jun 12, 2026 | filing ↗ |
| Alexander Fitzpatrick | $34K | Jun 12, 2026 | filing ↗ |
| Brian T. Dorsey | $190K | Nov 13, 2025 | filing ↗ |
| Chakma Justin | $1.2M | Nov 12, 2025 | filing ↗ |
| Justin Chakma | $267K | Nov 12, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 29, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |